Valuation : Meilleure Health International Industry Group Limited

Market Cap 969M 124M 106M 99.42M 90.99M 171M 11.81B 172M 1.18B 459M 5.96B 464M 454M 19.71B P/E 2024
36.7x
P/E 2025 28.5x
Enterprise Value 1.34B 171M 146M 137M 126M 236M 16.3B 237M 1.62B 634M 8.22B 640M 627M 27.19B EV / Sales 2024
28.8x
EV / Sales 2025 39.6x
Free-Float
30.93%
Yield 2024
1.38%
Yield 2025 2.08%
08-27 Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 CI
07-22 Meilleure Health International Industry Group Limited Announces Change of Registered Office Address in Hamilton CI
07-07 Meilleure Health Forecasts Rise in H1 Profit MT
07-07 Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2026 CI
06-26 Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025 CI
03-27 Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Meilleure Health International Industry Group Limited Recommends Payment of Final Dividend for the Year Ended December 31, 2025, Payable on August 28, 2026 CI
01-09 Meilleure Health to Acquire Chinese Property Leasing Firm for HK$137 Million MT
01-08 Meilleure Health International Industry to buy Jiangsu Yide for RMB124.8 million RE
01-08 Meilleure Health International Industry Group Limited signed a Equity Interest Transfer Agreement to acquire Jiangsu Yide Investment Company Limited from Zhou Chuan and Tan Wensheng for approximately CNY 120 million. CI
01-07 Meilleure Health International Industry Group Limited commences an Equity Buyback Plan for 409,375,663 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2025. CI
12-31 Meilleure Health International Industry Group Limited Announces Company Secretary Changes, Effective December 31, 2025 CI
12-31 Meilleure Health International Industry Group Limited Announces Changes in Nomination Committee, Effective December 31, 2025 CI
1 day-0.42%
1 week+0.42%
Current month-2.05%
1 month-4.40%
3 months-17.59%
6 months-6.27%
Current year-9.81%
1 week 0.23
Extreme 0.231
0.25
1 month 0.22
Extreme 0.22
0.26
Current year 0.21
Extreme 0.213
0.3
1 year 0.21
Extreme 0.213
0.31
3 years 0.11
Extreme 0.106
0.32
5 years 0.11
Extreme 0.106
0.48
10 years 0.11
Extreme 0.106
1.64
Manager TitleAgeSince
Chief Executive Officer 43 30/08/2013
Corporate Secretary 34 31/12/2025
Corporate Secretary 33 31/12/2025
Director TitleAgeSince
Chairman 70 30/08/2013
Director/Board Member 43 30/08/2013
Director/Board Member 64 30/08/2013
Date Insider Type Main position Quantity % Market Cap.
14/07/26 Other

Chairman

780,000 0.0192%
08/07/26 Other

Chief Executive Officer

240,000 0.0059%
02/01/26 Other

Chairman

13,914,000 0.3399%
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%+0.42%-4.40%-6.27% 124M
-1.12%-8.14%+59.79%+112.43% 1,060B
-1.57%-2.79%+50.59%+59.86% 651B
-1.81%-2.94%+23.90%+75.98% 465B
-1.17%-0.93%+40.43%+40.43% 365B
-2.00%-1.95%+23.06%+38.92% 300B
-0.98%+0.53%+2.04%+12.13% 258B
-0.76%-1.21%+50.90%+70.45% 238B
-3.18%-1.40%-15.87%-53.79% 210B
+0.52%+0.85%+29.73%+93.68% 184B
Average -1.25%-0.51%+26.02%+44.38% 373.05B
Weighted average by Cap. -1.36%-2.16%+38.56%+65.85%

Financials

2024 2025
Net sales 50.68M 6.47M 5.55M 5.2M 4.76M 8.96M 618M 8.99M 61.45M 24.02M 312M 24.27M 23.75M 1.03B 36.52M 4.66M 4M 3.75M 3.43M 6.45M 445M 6.48M 44.28M 17.31M 224M 17.49M 17.11M 743M
Net income 32.48M 4.14M 3.56M 3.33M 3.05M 5.74M 396M 5.76M 39.39M 15.4M 200M 15.56M 15.22M 661M 37.98M 4.85M 4.16M 3.9M 3.57M 6.71M 463M 6.74M 46.06M 18.01M 234M 18.19M 17.8M 772M
Net Debt 273M 34.84M 29.9M 28.02M 25.64M 48.27M 3.33B 48.45M 331M 129M 1.68B 131M 128M 5.55B 368M 46.93M 40.28M 37.74M 34.54M 65.02M 4.48B 65.25M 446M 174M 2.26B 176M 172M 7.48B
Logo Meilleure Health International Industry Group Limited
Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.
Employees
42
Date Price Change Volume
27/08/26 HK$0.2390 -0.42% 126,000
26/08/26 HK$0.2400 0.00% 0
25/08/26 HK$0.2400 +0.42% 66,000
24/08/26 HK$0.2390 -1.24% 156,000
21/08/26 HK$0.2420 +0.83% 60,000
  1. Stock Market
  2. Stocks
  3. 2327 Stock